free html templates

medicinal chemistry for start-ups

Address:

30 Victoria Rd
Burlingame, CA 94010

Phone:

1-650-787-8126

E-mail:

andrei@konradimolecular.com

Services

Drug discovery project evaluation, planning, and execution

Optimization of bioactive small molecules into drug candidates

Organic synthesis methods development

Execution of laboratory work at CROs in North America, Asia, and Europe

Composition of patent applications in collaboration with counsel

Principal

Andrei W. Konradi has twenty-five years of drug discovery research experience, and he has co-invented seven drug candidates that have been tested in humans.  Andrei has a BS in chemistry from MIT and a PhD in organic chemistry from Berkeley.

LinkedIn

Partner CROs

Konradi Molecular directs Partner CROs to execute projects for clients.  Konradi Molecular does not receive payments from Partner CROs.

Published patent applications, with links

14. Bicylic Compounds - Vivace Therapeutics

WO2020097389A1

13. Pyridine Derivatives - Amplyx Pharmaceuticals

WO2020005860A1

12. Oxadiazole Compounds - Vivace Therapeutics

WO2019222431A1

11. Benzocarbonyl Compounds - Vivace Therapeutics

WO2019113236A1

10. Benzosulfonyl Compounds - Vivace Therapeutics

WO2019040380A1

9. Aminopyridine Compounds - Cortexyme

WO2018209132A1

8. Non-fused Tricyclic Compounds - Vivace Therapeutics

WO2018204532A1

7. Ketone Inhibitors of Lysine Gingipain - Cortexyme

WO2018053353A1

6. Antibacterial Agents - Achaogen

WO2017223349A1

5. Prodrugs of Phenolic TRPV1 Agonists - Concentric Analgesics

WO2017147146A1

4. Inhibitors or Arginine Gingipain - Cortexyme

WO2017083433A1

3. Tricyclic Compounds - Vivace Therapeutics

WO2017058716A1

2. Inhibitors of Lysine Gingipain - Cortexyme

WO2016057413A2

1. Methods for Conjugating Activatable Antibodies - CytomX

WO2014197612A1

© Copyright 2019 Konradi Molecular - All Rights Reserved